Protecting Patients from Deceptive Drug Ads Online Act

Bill 118 s 5040, also known as the Protecting Patients from Deceptive Drug Ads Online Act, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to address the issue of deceptive drug advertisements that are being promoted online.

The bill aims to protect patients from misleading or false information about prescription drugs that they may come across while browsing the internet. It requires online platforms, such as social media websites and search engines, to take measures to ensure that drug advertisements are accurate and not deceptive.

Under this bill, online platforms would be required to verify the accuracy of drug advertisements before allowing them to be displayed to users. They would also need to provide clear and prominent disclosures about the risks and benefits of the advertised drugs. Additionally, the bill includes provisions for penalties for online platforms that fail to comply with these requirements. This could include fines or other enforcement actions. Overall, the Protecting Patients from Deceptive Drug Ads Online Act seeks to protect consumers from potentially harmful misinformation about prescription drugs that they may encounter online. It aims to ensure that patients have access to accurate and reliable information when making decisions about their healthcare.